-
21Shares Injective ETF: SEC Reviews Amended Filing
The SEC has received an amended S-1/A filing from 21Shares for its proposed Injective (INJ) ETF, signaling continued momentum in the altcoin ETF race. The move could accelerate institutional adoption and reshape how investors access mid-cap crypto assets.
-
21Shares to Launch First Spot ETF on HYPE Token
21Shares is set to launch the first spot ETF based on Hyperliquid’s HYPE token, with Nasdaq listing under the ticker THYP. Discover what this means for investors.